array(3) { ["company_details"]=> array(13) { ["name"]=> string(25) "ROCHE DIAGNOSTICS LIMITED" ["slug"]=> string(34) "ef866-gb-roche-diagnostics-limited" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/5ce04174-8fff-4069-9bd1-2ef80ada854c" ["description"]=> string(1583) "Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com/global/en Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation" ["address_street"]=> string(14) "Charles Avenue" ["address_place"]=> string(12) "BURGESS HILL" ["address_region"]=> NULL ["founding_date"]=> string(10) "1956-09-14" ["website_domain"]=> string(9) "roche.com" ["website_url"]=> string(29) "https://diagnostics.roche.com" ["industry_codes"]=> array(1) { [0]=> string(43) "Business Services, Not Elsewhere Classified" } ["employee_count"]=> int(658) ["article_count"]=> int(3438) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(57) "Understanding The Infringement Of Patents By Biosimilars." ["snippet_en"]=> string(124) "India - Understanding The Infringement Of Patents By Biosimilars. Legal News and Analysis - India - Intellectual Property -" ["url"]=> string(95) "https://conventuslaw.com/report/india-understanding-the-infringement-of-patents-by-biosimilars/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/5c92ae9a-ce85-488a-80d2-ef4a1110f883" ["source"]=> string(16) "conventuslaw.com" ["publication_date"]=> string(10) "2024-04-02" ["categories"]=> array(3) { [0]=> string(5) "Legal" [1]=> string(21) "Competitive Behaviour" [2]=> string(21) "Intellectual Property" } } [1]=> array(7) { ["title_en"]=> string(92) "Reducing regulatory data protection isn’t a successful strategy, says Roche Netherlands GM" ["snippet_en"]=> string(237) "Reducing regulatory data protection and limiting intellectual property rights isn’t a successful strategy, says Roche Netherlands' General Manager, while encouraging the Dutch government to follow Germany with a pharma strategy summit." ["url"]=> string(144) "https://www.euractiv.com/section/health-consumers/news/reducing-regulatory-data-protection-isnt-a-successful-strategy-says-roche-netherlands-gm/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e61f28e7-d2e3-4f19-b7fa-824117433737" ["source"]=> string(12) "euractiv.com" ["publication_date"]=> string(10) "2024-03-18" ["categories"]=> array(6) { [0]=> string(13) "Data Security" [1]=> string(11) "Legislation" [2]=> string(46) "Management of Legal and Regulatory Environment" [3]=> string(21) "Competitive Behaviour" [4]=> string(22) "EU Political Evolution" [5]=> string(16) "Customer Privacy" } } [2]=> array(7) { ["title_en"]=> string(65) "Roche completes acquisition of Carmot Therapeutics - TipRanks.com" ["snippet_en"]=> string(167) "Carmot Therapeutics announced that its acquisition by the Roche Group has been completed. Having successfully completed its acquisition of Carmot, Roche obtains acc..." ["url"]=> string(88) "https://www.tipranks.com/news/the-fly/roche-completes-acquisition-of-carmot-therapeutics" ["image_url"]=> NULL ["source"]=> string(12) "tipranks.com" ["publication_date"]=> string(10) "2024-01-29" ["categories"]=> array(4) { [0]=> string(21) "Competitive Behaviour" [1]=> string(11) "Acquisition" [2]=> string(18) "Expansion & Growth" [3]=> string(25) "Business Model Resilience" } } [3]=> array(7) { ["title_en"]=> string(108) "Stock market ticker: Swiss stock exchange without direction - Givaudan with a price gain of almost 8 percent" ["snippet_en"]=> string(84) "The Swiss stock exchange closed just in the black on the second-to-last trading day." ["url"]=> string(153) "https://www.cash.ch/news/top-news/borsen-ticker-smi-gibt-vor-ezb-zinsentscheid-nach-nestle-auf-2020-niveau-givaudan-im-aufwind-zehn-neue-kursziele-676997" ["image_url"]=> string(78) "https://images.businessradar.com/articles/d8728946-c400-408f-bfc6-d910a24a9563" ["source"]=> string(7) "cash.ch" ["publication_date"]=> string(10) "2024-01-25" ["categories"]=> array(14) { [0]=> string(13) "Credit Rating" [1]=> string(24) "Access and affordability" [2]=> string(31) "Financial Update/Profit Warning" [3]=> string(24) "Quarterly/Annual Figures" [4]=> string(24) "Stock Research & Ratings" [5]=> string(12) "Going Public" [6]=> string(11) "Sponsorship" [7]=> string(15) "Market Movement" [8]=> string(19) "Economic Conditions" [9]=> string(21) "Financial Performance" [10]=> string(20) "Contract negotiation" [11]=> string(9) "Investors" [12]=> string(21) "Competitive Behaviour" [13]=> string(12) "Stock Market" } } [4]=> array(7) { ["title_en"]=> string(156) "Stock market ticker: SMI gives in before ECB interest rate decision - Nestlé at 2020 level - Analyst sees Logitech 21 percent lower - Ten new price targets" ["snippet_en"]=> string(66) "The Swiss stock market fell slightly in early trading on Thursday." ["url"]=> string(169) "https://www.cash.ch/news/top-news/borsen-ticker-smi-vorborslich-tiefer-wieder-rekorde-an-der-wall-street-microsoft-setzt-hohenflug-fort-ezb-zinsentscheid-im-fokus-676997" ["image_url"]=> string(78) "https://images.businessradar.com/articles/73937f60-7b68-42d7-8c80-07b6e8c94c8d" ["source"]=> string(7) "cash.ch" ["publication_date"]=> string(10) "2024-01-25" ["categories"]=> array(8) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(24) "Stock Research & Ratings" [2]=> string(15) "Market Movement" [3]=> string(18) "Financial Distress" [4]=> string(19) "Economic Conditions" [5]=> string(9) "Investors" [6]=> string(21) "Competitive Behaviour" [7]=> string(12) "Stock Market" } } [5]=> array(7) { ["title_en"]=> string(60) "Roche is still hungry for agreements in the field of obesity" ["snippet_en"]=> string(112) "In December, Roche took over Carmot Therapeutics in a deal that could potentially amount to 3.1 billion. dollar." ["url"]=> string(39) "https://medwatch.dk/article16745135.ece" ["image_url"]=> string(78) "https://images.businessradar.com/articles/6a40ccd7-4370-4b5d-bdb5-b14e3d8747a1" ["source"]=> string(11) "medwatch.dk" ["publication_date"]=> string(10) "2024-01-10" ["categories"]=> array(2) { [0]=> string(15) "Deals & Tenders" [1]=> string(21) "Competitive Behaviour" } } [6]=> array(7) { ["title_en"]=> string(61) "Three Swiss companies among the 100 most popular in the world" ["snippet_en"]=> string(195) "While the United States accounts for more than half of the largest stock market capitalizations on the planet, the three heavyweights of the Swiss Market Index (SMI) have remained in the top 100." ["url"]=> string(108) "https://www.rfj.ch/rfj/Actualite/economie/Trois-entreprises-suisses-parmi-les-100-plus-prisees-du-globe.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/1f0a9b61-4b0d-4c91-9d16-f2caeff39020" ["source"]=> string(6) "rfj.ch" ["publication_date"]=> string(10) "2023-12-29" ["categories"]=> array(6) { [0]=> string(12) "Going Public" [1]=> string(11) "Competition" [2]=> string(15) "Market Movement" [3]=> string(9) "Valuation" [4]=> string(21) "Competitive Behaviour" [5]=> string(12) "Stock Market" } } [7]=> array(7) { ["title_en"]=> string(87) "Stock market ticker: Heavyweights pull SMI into the red - Kuros and Partners Group fall" ["snippet_en"]=> string(59) "The Swiss stock market was in the red on Wednesday morning." ["url"]=> string(134) "https://www.cash.ch/news/top-news/borsen-ticker-defensive-schwergewichte-sorgen-fur-minus-lonza-im-plus-partners-group-sackt-ab-669453" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3f307266-d804-403b-b46b-5ded4ff5782b" ["source"]=> string(7) "cash.ch" ["publication_date"]=> string(10) "2023-12-27" ["categories"]=> array(8) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(12) "Slash Prices" [2]=> string(11) "Competition" [3]=> string(15) "Market Movement" [4]=> string(19) "Economic Conditions" [5]=> string(21) "Competitive Behaviour" [6]=> string(12) "Stock Market" [7]=> string(17) "Commodity Pricing" } } [8]=> array(7) { ["title_en"]=> string(22) "Swiss Market Ends Flat" ["snippet_en"]=> string(217) "The Switzerland stock market ended flat on Wednesday after a choppy session. After an early uptick, the market briefly slipped into negative territory, and after staying positive till mid afternoon, turned weak again." ["url"]=> string(59) "https://www.rttnews.com/3412835/swiss-market-ends-flat.aspx" ["image_url"]=> NULL ["source"]=> string(11) "rttnews.com" ["publication_date"]=> string(10) "2023-12-20" ["categories"]=> array(4) { [0]=> string(21) "Competitive Behaviour" [1]=> string(12) "Stock Market" [2]=> string(15) "Market Movement" [3]=> string(8) "Downtime" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(217) } [1]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(204) } [2]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(192) } [3]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(156) } [4]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(153) } [5]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(148) } [6]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(137) } [7]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(136) } [8]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(111) } [9]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(105) } [10]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(102) } [11]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(97) } [12]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(92) } [13]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(89) } [14]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(86) } [15]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(69) } [16]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(65) } [17]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(64) } [18]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(63) } [19]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(49) } [20]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(42) } [21]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(40) } [22]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(40) } [23]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(38) } [24]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(33) } [25]=> array(2) { ["name"]=> string(12) "Staff hiring" ["count"]=> int(33) } [26]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(32) } [27]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(32) } [28]=> array(2) { ["name"]=> string(7) "Layoffs" ["count"]=> int(32) } [29]=> array(2) { ["name"]=> string(16) "Customer Welfare" ["count"]=> int(32) } } } ef866-gb-roche-diagnostics-limited